A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer
Clinical trial NCT03573960 · COMPLETED
Trial details
- NCT number
- NCT03573960
- Sponsor
- Eisai Pharmaceuticals India Pvt. Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-01
- Primary completion
- 2025-09-04
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.